Aquaporin-4 antibody in neuromyelitis optica: re-testing study in a large population from China

References

• Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364(9451):2106–12.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66(10):1485–9.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6(9):805–15.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85(2):177–89.
   PubMed Web of Science ®Google Scholar
• Jarius S, Wildemann B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol 2013;23(6):661–83.
   PubMed Web of Science ®Google Scholar
• Pisani F, Sparaneo A, Tortorella C, et al. Aquaporin-4 autoantibodies in neuromyelitis optica: AQP4 isoform-dependent sensitivity and specificity. PLOS ONE 2013;8(11):e79185.
   PubMed Web of Science ®Google Scholar
• Jarius S, Paul F, Fechner K, et al. Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate. J Neuroinflamm 2014;11:129.
   PubMed Web of Science ®Google Scholar
• Crane JM, Lam C, Rossi A, et al. Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays. J Biol Chem 2011;286(18):16516–24.
   PubMed Web of Science ®Google Scholar
• Marignier R, Bernard-Valnet R, Giraudon P, et al. Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology 2013;80(24):2194–200.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Fryer JP, Lennon VA, et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology 2013;81(14):1197–204.
   PubMed Web of Science ®Google Scholar
• Fujihara K, Leite MI. Seronegative NMO: a sensitive AQP4 antibody test clarifies clinical features and next challenges. Neurology 2013;80(24):2176–7.
   PubMed Web of Science ®Google Scholar
• Fujihara K, Sato DK. AQP4 antibody serostatus: is its luster being lost in the management and pathogenesis of NMO. Neurology 2013;81(14):1186–8.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Fujihara K, Nakashima I, et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006;210(4):307–13.
   PubMed Web of Science ®Google Scholar
• Fujihara K, Leite MI. Seronegative NMO: a sensitive AQP4 antibody test clarifies clinical features and next challenges. Neurology 2013;80(24):2176–7.
   PubMed Web of Science ®Google Scholar
• Long Y, Qiu W, Lu Z, et al. Aquaporin 4 antibodies in the cerebrospinal fluid are helpful in diagnosing Chinese patients with neuromyelitis optica. Neuroimmunomodulation 2012;19(2):96–102.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(2):292–302.
   PubMed Web of Science ®Google Scholar
• Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002;59(4):499–505.
   PubMed Web of Science ®Google Scholar
• Scott TF, Kassab SL, Pittock SJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 2006;63(10):1398–400.
   PubMedGoogle Scholar
• Fazio R, Malosio ML, Lampasona V, et al. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler 2009;15(10):1153–63.
   PubMed Web of Science ®Google Scholar
• Nicchia GP, Mastrototaro M, Rossi A, et al. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia 2009;57(13):1363–73.
   PubMed Web of Science ®Google Scholar
• Jarius S, Probst C, Borowski K, et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci 2010;291(1–2):52–6.
   PubMed Web of Science ®Google Scholar
• Rossi A1, Pisani F, Nicchia GP, et al. Evidences for a leaky scanning mechanism for the synthesis of the shorter M23 protein isoform of aquaporin-4: implication in orthogonal array formation and neuromyelitis optica antibody interaction. J Biol Chem 2010;285(7):4562–9.
   PubMed Web of Science ®Google Scholar
• Pisani F, Rossi A, Nicchia GP, et al. Translational regulation mechanisms of aquaporin-4 supramolecular organization in astrocytes. Glia 2011;59(12):1923–32.
   PubMed Web of Science ®Google Scholar
• Fryer JP, Lennon VA, Pittock SJ, et al. AQP4 autoantibody assay performance in clinical laboratory service. Neurol Neuroimmunol Neuroinflamm 2014;1(1):e11.
   PubMedGoogle Scholar
• Klawiter EC, Alvarez E 3rd, Xu J, et al. NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology 2009;72(12):1101–3.
   PubMed Web of Science ®Google Scholar
• Majed M, Fryer JP, McKeon A, et al. Clinical utility of testing AQP4-IgG in CSF: guidance for physicians. Neurol Neuroimmunol Neuroinflamm 2016;3(3):e231.
   PubMed Web of Science ®Google Scholar
• Tuller F, Holzer H, Schanda K, et al. Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders. J Neuroinflamm 2016;13(1):176.
   PubMed Web of Science ®Google Scholar
• Mader S, Gredler V, Schanda K, et al. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflamm 2011. 28(8):184.
   PubMed Web of Science ®Google Scholar
• Jarius S, Wandinger KP, Borowski K, et al. Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg 2012;114(4):331–5.
   PubMed Web of Science ®Google Scholar